Quoting Paola Anna Jablonska, Radiation Oncology Staff at Hospital Universitario de Navarra on LinkedIn:
“We published the Princess Margaret Cancer Centre experience on toxicity of melanoma BMs. Symptomatic intralesional hemorrhage was much more common than symptomatic radiation necrosis following SRS, delivered with or without concurrent/sequential immunotherapy.
Take a look at the discussion, reflecting on the current challenges with reporting SRS-associated toxicity & brain metastases outcomes in the era of immunotherapy.”
For the article click here.
Source: Paola Anna Jablonska/LinkedIn